We are live on ! Find out more
MAIA icon

MAIA Biotechnology
MAIA

21 hedge funds and large institutions have $6.09M invested in MAIA Biotechnology in 2024 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

305% more capital invested

Capital invested by funds: $1.5M → $6.09M (+$4.59M)

125% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 4

25% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 4

5% more funds holding

Funds holding: 20 → 21 (+1)

4.88% more ownership

Funds ownership: 3.3% → 8.19% (+4.9%)

Holders
21
Holders Change
+1
Holders Change %
+5%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
9
Reduced
4
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
HFF
Halter Ferguson Financial
Indiana
+$2.27M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$805K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$326K
4
BlackRock
BlackRock
New York
+$194K
5
GSC
Ground Swell Capital
South Carolina
+$51.9K

Top Sellers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
-$71K
2
Citadel Advisors
Citadel Advisors
Florida
-$52.2K
3
Renaissance Technologies
Renaissance Technologies
New York
-$42K
4
Jane Street
Jane Street
New York
-$41.4K
5
Morgan Stanley
Morgan Stanley
New York
-$15.8K
Name Holding Trade Value Shares
Change 		Change in
Stake
HFF
1
Halter Ferguson Financial
Indiana
$2.47M +$2.27M +721,665 New
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.84M +$805K +255,339 +91%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$536K +$326K +103,485 +194%
BlackRock
4
BlackRock
New York
$269K +$194K +61,529 +362%
CWM
5
Centric Wealth Management
Illinois
$226K +$3.15K +1,000 +1%
BCM
6
Bridgeway Capital Management
Texas
$156K – – –
State Street
7
State Street
Massachusetts
$118K +$41.3K +13,100 +62%
Northern Trust
8
Northern Trust
Illinois
$110K +$37.2K +11,798 +58%
NW
9
Naviter Wealth
Arkansas
$75.8K – – –
GSC
10
Ground Swell Capital
South Carolina
$56.3K +$51.9K +16,460 New
Verition Fund Management
11
Verition Fund Management
Connecticut
$52.6K +$48.4K +15,372 New
Wealth Enhancement Advisory Services
12
Wealth Enhancement Advisory Services
Minnesota
$50.6K -$3.78K -1,200 -8%
Jane Street
13
Jane Street
New York
$40.8K -$41.4K -13,135 -52%
OAC
14
OMERS Administration Corp
Ontario, Canada
$36.9K +$34K +10,800 New
MG
15
Mather Group
Illinois
$26.5K +$37.9K +12,036 +50,150%
Morgan Stanley
16
Morgan Stanley
New York
$17.4K -$15.8K -5,000 -50%
TRCT
17
Tower Research Capital (TRC)
New York
$16.2K -$2.92K -926 -16%
Bank of America
18
Bank of America
North Carolina
$469 +$432 +137 New
SS
19
Sunbelt Securities
Texas
$342 – – –
JP Morgan Chase
20
JP Morgan Chase
New York
$140 +$9 +3 +8%
VF
21
Virtu Financial
New York
– -$71K -32,487 Closed
Citadel Advisors
22
Citadel Advisors
Florida
– -$52.2K -23,749 Closed
Renaissance Technologies
23
Renaissance Technologies
New York
– -$42K -19,000 Closed
Wells Fargo
24
Wells Fargo
California
– -$200 -91 Closed
Royal Bank of Canada
25
Royal Bank of Canada
Ontario, Canada
– +$183 +58 +207%

MAIA Hedge Fund Activity: Q2 2024 in Review

21 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in MAIA Biotechnology (MAIA) for Q2 2024, worth a combined $6.09M — up 305% from $1.5M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new MAIA positions and 4 closed out — a net gain of 1 holder — while 9 added to existing stakes and 4 trimmed.

The largest buyer was Halter Ferguson Financial, opening a new position worth an estimated $2.27M. The largest seller was Virtu Financial, exiting entirely with an estimated $71K sold.

  • 21 institutional investors held MAIA Biotechnology (MAIA) as of Q2 2024, up from 20 in Q1 2024.
  • Funds reported $6.09M of MAIA Biotechnology stock for Q2 2024, up 305% quarter-over-quarter.
  • 5 funds opened new MAIA Biotechnology positions in Q2 2024 and 4 closed out, a net change of +1 holder.
  • The largest MAIA Biotechnology buyer in Q2 2024 was Halter Ferguson Financial, an estimated $2.27M added.
  • The largest MAIA Biotechnology seller in Q2 2024 was Virtu Financial, an estimated $71K sold.

Based on aggregated 13F filings for Q2 2024.